Suppression of dynamin GTPase decreases -synuclein uptake by neuronal and oligodendroglial cells: A potent therapeutic target for synucleinopathy

Masatoshi Konno, Takafumi Hasegawa, Toru Baba, Emiko Miura, Naoto Sugeno, Akio Kikuchi, Fabienne Fiesel, Tsutomu Sasaki, Masashi Aoki, Yasuto Itoyama, Atsushi Takeda

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Background: The intracellular deposition of misfolded proteins is a common neuropathological hallmark of most neurodegenerative disorders. Increasing evidence suggests that these pathogenic proteins may spread to neighboring cells and induce the propagation of neurodegeneration. Results: In this study, we have demonstrated that -synuclein (SYN), a major constituent of intracellular inclusions in synucleinopathies, was taken up by neuronal and oligodendroglial cells in both a time- and concentration-dependent manner. Once incorporated, the extracellular SYN was immediately assembled into high-molecular-weight oligomers and subsequently formed cytoplasmic inclusion bodies. Furthermore, SYN uptake by neurons and cells of the oligodendroglial lineage was markedly decreased by the genetic suppression and pharmacological inhibition of the dynamin GTPases, suggesting the involvement of the endocytic pathway in this process. Conclusions: Our findings shed light on the mode of SYN uptake by neuronal and oligodendroglial cells and identify therapeutic strategies aimed at reducing the propagation of protein misfolding.

Original languageEnglish (US)
Article number38
JournalMolecular neurodegeneration
Volume7
Issue number1
DOIs
StatePublished - Aug 17 2012

Fingerprint

Synucleins
Dynamins
GTP Phosphohydrolases
Inclusion Bodies
Genetic Suppression
Proteins
Cell Lineage
Therapeutics
Neurodegenerative Diseases
Molecular Weight
Pharmacology
Neurons

Keywords

  • -synuclein
  • Dynamin
  • Endocytosis
  • Inclusions
  • Multiple system atrophy
  • Neuron
  • Oligodendroglia
  • Parkinsons disease
  • Sertraline
  • Transmission

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Suppression of dynamin GTPase decreases -synuclein uptake by neuronal and oligodendroglial cells : A potent therapeutic target for synucleinopathy. / Konno, Masatoshi; Hasegawa, Takafumi; Baba, Toru; Miura, Emiko; Sugeno, Naoto; Kikuchi, Akio; Fiesel, Fabienne; Sasaki, Tsutomu; Aoki, Masashi; Itoyama, Yasuto; Takeda, Atsushi.

In: Molecular neurodegeneration, Vol. 7, No. 1, 38, 17.08.2012.

Research output: Contribution to journalArticle

Konno, Masatoshi ; Hasegawa, Takafumi ; Baba, Toru ; Miura, Emiko ; Sugeno, Naoto ; Kikuchi, Akio ; Fiesel, Fabienne ; Sasaki, Tsutomu ; Aoki, Masashi ; Itoyama, Yasuto ; Takeda, Atsushi. / Suppression of dynamin GTPase decreases -synuclein uptake by neuronal and oligodendroglial cells : A potent therapeutic target for synucleinopathy. In: Molecular neurodegeneration. 2012 ; Vol. 7, No. 1.
@article{95bd3c20f8d14f50b5363fcd36720402,
title = "Suppression of dynamin GTPase decreases -synuclein uptake by neuronal and oligodendroglial cells: A potent therapeutic target for synucleinopathy",
abstract = "Background: The intracellular deposition of misfolded proteins is a common neuropathological hallmark of most neurodegenerative disorders. Increasing evidence suggests that these pathogenic proteins may spread to neighboring cells and induce the propagation of neurodegeneration. Results: In this study, we have demonstrated that -synuclein (SYN), a major constituent of intracellular inclusions in synucleinopathies, was taken up by neuronal and oligodendroglial cells in both a time- and concentration-dependent manner. Once incorporated, the extracellular SYN was immediately assembled into high-molecular-weight oligomers and subsequently formed cytoplasmic inclusion bodies. Furthermore, SYN uptake by neurons and cells of the oligodendroglial lineage was markedly decreased by the genetic suppression and pharmacological inhibition of the dynamin GTPases, suggesting the involvement of the endocytic pathway in this process. Conclusions: Our findings shed light on the mode of SYN uptake by neuronal and oligodendroglial cells and identify therapeutic strategies aimed at reducing the propagation of protein misfolding.",
keywords = "-synuclein, Dynamin, Endocytosis, Inclusions, Multiple system atrophy, Neuron, Oligodendroglia, Parkinsons disease, Sertraline, Transmission",
author = "Masatoshi Konno and Takafumi Hasegawa and Toru Baba and Emiko Miura and Naoto Sugeno and Akio Kikuchi and Fabienne Fiesel and Tsutomu Sasaki and Masashi Aoki and Yasuto Itoyama and Atsushi Takeda",
year = "2012",
month = "8",
day = "17",
doi = "10.1186/1750-1326-7-38",
language = "English (US)",
volume = "7",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Suppression of dynamin GTPase decreases -synuclein uptake by neuronal and oligodendroglial cells

T2 - A potent therapeutic target for synucleinopathy

AU - Konno, Masatoshi

AU - Hasegawa, Takafumi

AU - Baba, Toru

AU - Miura, Emiko

AU - Sugeno, Naoto

AU - Kikuchi, Akio

AU - Fiesel, Fabienne

AU - Sasaki, Tsutomu

AU - Aoki, Masashi

AU - Itoyama, Yasuto

AU - Takeda, Atsushi

PY - 2012/8/17

Y1 - 2012/8/17

N2 - Background: The intracellular deposition of misfolded proteins is a common neuropathological hallmark of most neurodegenerative disorders. Increasing evidence suggests that these pathogenic proteins may spread to neighboring cells and induce the propagation of neurodegeneration. Results: In this study, we have demonstrated that -synuclein (SYN), a major constituent of intracellular inclusions in synucleinopathies, was taken up by neuronal and oligodendroglial cells in both a time- and concentration-dependent manner. Once incorporated, the extracellular SYN was immediately assembled into high-molecular-weight oligomers and subsequently formed cytoplasmic inclusion bodies. Furthermore, SYN uptake by neurons and cells of the oligodendroglial lineage was markedly decreased by the genetic suppression and pharmacological inhibition of the dynamin GTPases, suggesting the involvement of the endocytic pathway in this process. Conclusions: Our findings shed light on the mode of SYN uptake by neuronal and oligodendroglial cells and identify therapeutic strategies aimed at reducing the propagation of protein misfolding.

AB - Background: The intracellular deposition of misfolded proteins is a common neuropathological hallmark of most neurodegenerative disorders. Increasing evidence suggests that these pathogenic proteins may spread to neighboring cells and induce the propagation of neurodegeneration. Results: In this study, we have demonstrated that -synuclein (SYN), a major constituent of intracellular inclusions in synucleinopathies, was taken up by neuronal and oligodendroglial cells in both a time- and concentration-dependent manner. Once incorporated, the extracellular SYN was immediately assembled into high-molecular-weight oligomers and subsequently formed cytoplasmic inclusion bodies. Furthermore, SYN uptake by neurons and cells of the oligodendroglial lineage was markedly decreased by the genetic suppression and pharmacological inhibition of the dynamin GTPases, suggesting the involvement of the endocytic pathway in this process. Conclusions: Our findings shed light on the mode of SYN uptake by neuronal and oligodendroglial cells and identify therapeutic strategies aimed at reducing the propagation of protein misfolding.

KW - -synuclein

KW - Dynamin

KW - Endocytosis

KW - Inclusions

KW - Multiple system atrophy

KW - Neuron

KW - Oligodendroglia

KW - Parkinsons disease

KW - Sertraline

KW - Transmission

UR - http://www.scopus.com/inward/record.url?scp=84864915936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864915936&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-7-38

DO - 10.1186/1750-1326-7-38

M3 - Article

C2 - 22892036

AN - SCOPUS:84864915936

VL - 7

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 38

ER -